U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Hypernatriuria

MedGen UID:
854169
Concept ID:
C3671887
Disease or Syndrome; Finding
Synonym: Increased urinary sodium
 
HPO: HP:0012605

Definition

An increased concentration of sodium(1+) in the urine. [from HPO]

Conditions with this feature

Nephrogenic syndrome of inappropriate antidiuresis
MedGen UID:
336877
Concept ID:
C1845202
Disease or Syndrome
The syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a common cause of hyponatremia. The syndrome manifests as an inability to excrete a free water load, with inappropriately concentrated urine and resultant hyponatremia, hypoosmolality, and natriuresis. SIADH occurs in a setting of normal blood volume, without evidence of renal disease or deficiency of thyroxine or cortisol. Although usually transient, SIADH may be chronic; it is often associated with drug use or a lesion in the central nervous system or lung. When the cardinal features of SIADH were defined by Bartter and Schwartz (1967), levels of AVP could not be measured. Subsequently, radioimmunoassays revealed that SIADH is usually associated with measurably elevated serum levels of AVP. Nephrogenic syndrome of inappropriate antidiuresis (NSIAD) is characterized by a clinical picture similar to SIADH, but is associated with undetectable levels of AVP (Feldman et al., 2005).
Bartter disease type 4A
MedGen UID:
355430
Concept ID:
C1865270
Disease or Syndrome
Bartter syndrome refers to a group of disorders that are unified by autosomal recessive transmission of impaired salt reabsorption in the thick ascending loop of Henle with pronounced salt wasting, hypokalemic metabolic alkalosis, and hypercalciuria. Clinical disease results from defective renal reabsorption of sodium chloride in the thick ascending limb (TAL) of the Henle loop, where 30% of filtered salt is normally reabsorbed (Simon et al., 1997). Patients with antenatal (or neonatal) forms of Bartter syndrome typically present with premature birth associated with polyhydramnios and low birth weight and may develop life-threatening dehydration in the neonatal period. Patients with classic Bartter syndrome (see BARTS3, 607364) present later in life and may be sporadically asymptomatic or mildly symptomatic (summary by Simon et al., 1996 and Fremont and Chan, 2012). For a discussion of genetic heterogeneity of Bartter syndrome, see 607364.
Bartter disease type 4B
MedGen UID:
934772
Concept ID:
C4310805
Disease or Syndrome
Bartter syndrome refers to a group of disorders that are unified by autosomal recessive transmission of impaired salt reabsorption in the thick ascending loop of Henle with pronounced salt wasting, hypokalemic metabolic alkalosis, and hypercalciuria. Clinical disease results from defective renal reabsorption of sodium chloride in the thick ascending limb (TAL) of the Henle loop, where 30% of filtered salt is normally reabsorbed (Simon et al., 1997). Patients with antenatal (or neonatal) forms of Bartter syndrome (e.g., BARTS1, 601678) typically present with premature birth associated with polyhydramnios and low birth weight and may develop life-threatening dehydration in the neonatal period. Patients with classic Bartter syndrome present later in life and may be sporadically asymptomatic or mildly symptomatic (summary by Simon et al., 1996 and Fremont and Chan, 2012). For a discussion of genetic heterogeneity of Bartter syndrome, see 607364.

Recent clinical studies

Etiology

Oğuz ID, Oğuz U, Usta M, Kulaklı S, Tosun A, Demirelli E, Akşan B, Emecen Ö, Yüzüak E
J Dermatol 2024 Feb;51(2):280-286. Epub 2023 Dec 12 doi: 10.1111/1346-8138.17058. PMID: 38087833
Khargi R, Blake RM, Yaghoubian AJ, Canning C, Fang A, Connors C, Gallante B, Ricapito A, Khusid JA, Atallah WM, Gupta M
World J Urol 2023 Dec;41(12):3713-3721. Epub 2023 Oct 17 doi: 10.1007/s00345-023-04619-1. PMID: 37847263
Brinkman JE, Large T, Nottingham CU, Stoughton C, Krambeck AE
J Endourol 2021 Oct;35(10):1555-1562. Epub 2021 May 20 doi: 10.1089/end.2020.1035. PMID: 33573466
Herrera Valdés R, Almaguer López M, Orantes Navarro CM, López Marín L, Brizuela Díaz EG, Bayarre Vea H, Amaya Medina JC, Silva Ayçaguer LC, Vela Parada XF, Zelaya Quezada S, Orellana de Figueroa P, Smith González M, Chávez Muñoz Y, García Ortiz XA, Bacallao Méndez R
Clin Nephrol 2020 Supplement-Jan;93(1):60-67. doi: 10.5414/CNP92S110. PMID: 31699212
Herrera R, Orantes CM, Almaguer M, Alfonso P, Bayarre HD, Leiva IM, Smith MJ, Cubias RA, Torres CG, Almendárez WO, Cubias FR, Morales FE, Magaña S, Amaya JC, Perdomo E, Ventura MC, Villatoro JF, Vela XF, Zelaya SM, Granados DV, Vela E, Orellana P, Hevia R, Fuentes EJ, Mañalich R, Bacallao R, Ugarte M, Arias MI, Chávez J, Flores NE, Aparicio CE
MEDICC Rev 2014 Apr;16(2):39-48. doi: 10.37757/MR2014.V16.N2.7. PMID: 24878648

Diagnosis

Oğuz ID, Oğuz U, Usta M, Kulaklı S, Tosun A, Demirelli E, Akşan B, Emecen Ö, Yüzüak E
J Dermatol 2024 Feb;51(2):280-286. Epub 2023 Dec 12 doi: 10.1111/1346-8138.17058. PMID: 38087833
Kim YM, Seo GH, Kim GH, Ko JM, Choi JH, Yoo HW
BMC Med Genet 2018 Mar 5;19(1):35. doi: 10.1186/s12881-018-0546-4. PMID: 29506479Free PMC Article
Freitas Junior CH, Mazzucchi E, Danilovic A, Brito AH, Srougi M
Clinics (Sao Paulo) 2012;67(5):457-61. doi: 10.6061/clinics/2012(05)09. PMID: 22666789Free PMC Article
Schmidt H, Kabesch M, Schwarz HP, Kiess W
Horm Metab Res 2001 Jun;33(6):354-7. doi: 10.1055/s-2001-15417. PMID: 11456284

Therapy

Herrera Valdés R, Almaguer López M, Orantes Navarro CM, López Marín L, Brizuela Díaz EG, Bayarre Vea H, Amaya Medina JC, Silva Ayçaguer LC, Vela Parada XF, Zelaya Quezada S, Orellana de Figueroa P, Smith González M, Chávez Muñoz Y, García Ortiz XA, Bacallao Méndez R
Clin Nephrol 2020 Supplement-Jan;93(1):60-67. doi: 10.5414/CNP92S110. PMID: 31699212
Kim YM, Seo GH, Kim GH, Ko JM, Choi JH, Yoo HW
BMC Med Genet 2018 Mar 5;19(1):35. doi: 10.1186/s12881-018-0546-4. PMID: 29506479Free PMC Article
Herrera Valdés R, Orantes CM, Almaguer López M, López Marín L, Arévalo PA, Smith González MJ, Morales FE, Bacallao R, Bayarre HD, Vela Parada XF
Clin Nephrol 2015;83(7 Suppl 1):56-63. doi: 10.5414/cnp83s056. PMID: 25725244
Herrera R, Orantes CM, Almaguer M, Alfonso P, Bayarre HD, Leiva IM, Smith MJ, Cubias RA, Torres CG, Almendárez WO, Cubias FR, Morales FE, Magaña S, Amaya JC, Perdomo E, Ventura MC, Villatoro JF, Vela XF, Zelaya SM, Granados DV, Vela E, Orellana P, Hevia R, Fuentes EJ, Mañalich R, Bacallao R, Ugarte M, Arias MI, Chávez J, Flores NE, Aparicio CE
MEDICC Rev 2014 Apr;16(2):39-48. doi: 10.37757/MR2014.V16.N2.7. PMID: 24878648

Clinical prediction guides

Brinkman JE, Large T, Nottingham CU, Stoughton C, Krambeck AE
J Endourol 2021 Oct;35(10):1555-1562. Epub 2021 May 20 doi: 10.1089/end.2020.1035. PMID: 33573466
Herrera R, Orantes CM, Almaguer M, Alfonso P, Bayarre HD, Leiva IM, Smith MJ, Cubias RA, Torres CG, Almendárez WO, Cubias FR, Morales FE, Magaña S, Amaya JC, Perdomo E, Ventura MC, Villatoro JF, Vela XF, Zelaya SM, Granados DV, Vela E, Orellana P, Hevia R, Fuentes EJ, Mañalich R, Bacallao R, Ugarte M, Arias MI, Chávez J, Flores NE, Aparicio CE
MEDICC Rev 2014 Apr;16(2):39-48. doi: 10.37757/MR2014.V16.N2.7. PMID: 24878648

Supplemental Content

Table of contents

    Clinical resources

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...